指南与共识骨质疏松与代谢性骨病

骨质疏松临床实践指南未提供患者信念、价值观与偏好的证据

Evidence of patient beliefs, values, and preferences is not provided in osteoporosis clinical practice guidelines.
指南 / 共识 · Osteoporos Int · 2019-03-11

该文档分析基于国际骨质疏松基金会网站检索的英文国际骨质疏松指南,评估患者信念、价值观与偏好(BVPs)的纳入和概念化情况。70部指南中27部(39%)提及BVPs共95条陈述,其中14部将BVPs概念化为对某种药物的偏好,19部提及重要性但无原始研究或系统综述支持。作者建议指南纳入定性数据作为BVPs证据。

要点

  • 70部国际骨质疏松指南中27部(39%)提及患者信念、价值观与偏好(BVPs),共95条陈述。
  • BVPs最常被概念化为对某种药物优于另一种的偏好(14部指南)。
  • 19部指南提及BVPs重要性但无原始研究或系统综述支持。

核心结论

  • 27部(39%)指南提及患者BVPs;19部指南提及BVPs重要性但无原始研究或系统综述支持;BVPs最常(14部指南)被概念化为对某种药物的偏好;作者建议指南纳入定性数据作为BVPs证据。

研究设计与样本

  • 基于国际骨质疏松基金会网站的英文国际骨质疏松指南进行文档分析,由两名独立研究者审查BVPs相关陈述,分歧由第一作者解决,并基于五个共同元素建立分类。

主要发现

  • 70部指南中27部(39%)包含95条关于患者BVPs的陈述。
  • 95条陈述中,32条(14部指南)归类为与药物治疗或一般治疗选择相关的BVPs。
  • 10条(7部指南)归类为与药物治疗或一般治疗依从性相关的BVPs。
  • 5条(5部指南)归类为与财务成本和收益相关的BVPs。
  • 43条(19部指南)归类为提及但无原始研究或系统综述参考文献支持的其他BVPs;5条(3部指南)归类为提及且至少有一篇原始研究或系统综述参考文献支持的其他BVPs。

关键数值与推荐

  • 共引用29篇参考文献反映所提及的BVPs,包括一篇社论和定量研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We examined how patient beliefs, values, and preferences (BVPs) were included and conceptualized in international osteoporosis guidelines. The majority of guidelines did not mention BVPs. When mentioned, BVPs were conceptualized as preference for one medication over another. A broader conceptualization and inclusion of BVPs should be incorporated in osteoporosis guidelines. INTRODUCTION: Our objectives were to determine (1) the extent to which osteoporosis guidelines reflected patients' beliefs, values, and preferences (BVPs); (2) how BVPs were conceptualized; and (3) the methods used to elicit BVPs in the references cited by the guidelines. METHODS: We conducted a document analysis of English-language international osteoporosis guidelines based on the International Osteoporosis Foundation website. We examined each guideline and extracted all instances of statements pertaining to BVPs. The statements were reviewed by two independent researchers. Discrepancies in data extraction were resolved by the first author. We developed categories based on five common elements that represented the BVP statements. RESULTS: Twenty-seven of 70 (39%) guidelines included 95 statements about patient BVPs. Of the 95 statements, 32 statements (14 guidelines) were classified under BVP related to the choice of pharmacotherapy or general treatment, 10 (7 guidelines) under BVP related to adherence to pharmacotherapy or treatment in general, 5 (5 guidelines) under BVP related to financial costs and benefits, 43 (19 guidelines) under other BVP mentioned but not supported by a reference to a primary study or systematic review, and 5 (3 guidelines) under other BVP mentioned and supported by at least one reference to a primary study or systematic review. Twenty-nine references were cited to reflect the BVPs mentioned, including an editorial and quantitative studies. CONCLUSIONS: Twenty-seven (39%) of the guidelines included mention of patients' BVPs. In 19 guidelines, the importance of BVPs was mentioned but these statements were not supported by references to a primary study or systematic review. BVPs were most often (14 guidelines) conceptualized as preference for one medication over another. We suggest that qualitative data be included as evidence of BVPs in guidelines.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Sale JEM, Marwah A, Naeem F, et al. Evidence of patient beliefs, values, and preferences is not provided in osteoporosis clinical practice guidelines. Osteoporos Int. 2019. PMID: 30859238. doi:10.1007/s00198-019-04913-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。